Abstract:This paper reviews the body of evidence that major depression is accompanied by a decreased antioxidant status and by induction of oxidative and nitrosative (IO&NS) pathways. Major depression is characterized by significantly lower plasma concentrations of a number of key antioxidants, such as vitamin E, zinc and coenzyme Q10, and a lowered total antioxidant status. Lowered antioxidant enzyme activity, e.g. glutathione peroxidase (GPX), is another hallmark of depression. The abovementioned lowered antioxidant capacity may impair protection against reactive oxygen species (ROS), causing damage to fatty acids, proteins and DNA by oxidative and nitrosative stress (O&NS). Increased ROS in depression is demonstrated by increased levels of plasma peroxides and xanthine oxidase. Damage caused by O&NS is shown by increased levels of malondialdehyde (MDA), a by-product of polyunsaturated fatty acid peroxidation and arachidonic acid; and increased 8-hydroxy-2-deoxyguanosine, indicating oxidative DNA damage. There is also evidence in major depression, that O&NS may have changed inactive autoepitopes to neoantigens, which have acquired immunogenicity and serve as triggers to bypass immunological tolerance, causing (auto)immune responses. Thus, depression is accompanied by increased levels of plasma IgG antibodies against oxidized LDL; and increased IgM-mediated immune responses against membrane fatty acids, like phosphatidyl inositol (Pi); oleic, palmitic, and myristic acid; and NO modified amino-acids, e.g. NO-tyrosine, NO-tryptophan and NO-arginine; and NO-albumin. There is a significant association between depression and polymorphisms in O&NS genes, like manganese superoxide dismutase, catalase, and myeloperoxidase. Animal models of depression very consistently show lowered antioxidant defences and activated O&NS pathways in the peripheral blood and the brain. In animal models of depression, antidepressants consistently increase lowered antioxidant levels and normalize the damage caused by O&NS processes. Antioxidants, such as N-acetyl-cysteine, compounds that mimic GPX activity, and zinc exhibit antidepressive effects. This paper reviews the pathways by which lowered antioxidants and O&NS may contribute to depression, and the (neuro)degenerative processes that accompany that illness. It is concluded that aberrations in O&NS pathways are - together with the inflammatory processes - key components of depression. All in all, the results suggest that depression belongs to the spectrum of (neuro)degenerative disorders.

The Changes of Oxidative Stress and Human 8-Hydroxyguanine Glycosylase1 Gene Expression in Depressive Patients with Acute Leukemia.

Relationship Between Oxidative Stress and Depression in Patients with Acute Leukemia

Aromatase Changes in Depression: A Postmortem and Animal Experimental Study.

Imbalanced Free Radicals and Antioxidant Defense Systems in Schizophrenia: A Comparative Study

Oxidative Stress In Depressive Patients With Gastric Adenocarcinoma

The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma.

A Meta-Analysis of Oxidative Stress Markers in Depression

Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia

Depression status in patients with acute leukemia treated by chemotherapy

The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression

Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages

Oxidative stress status in bipolar disorder patients with depression episode

Increased 8-Hydroxy-deoxyguanosine, A Marker of Oxidative Damage to Dna, in Major Depression and Myalgic Encephalomyelitis Chronic Fatigue Syndrome

Disrupted NAD(P) Metabolism and Xanthine Dehydrogenase in a Stress-Induced Rat Model of Depression: NMR Metabolomics Insights

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

Oxidative stress markers in affective disorders

The impact of ACTH levels on neurotransmitters and antioxidants in patients with major depressive disorder: A novel investigation

Oxidative stress in leukemia and antioxidant treatment

Expression of nm23 and NDRG1 Proteins in Ovarian Cancer Tumor Model of Depression

Association of Oxidative Stress with Realgar-Induced Differentiation in Human Leukemia HL-60 Cells

Aberrations in Oxidative Stress Markers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis